These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10925271)

  • 1. CD81 and CD28 costimulate T cells through distinct pathways.
    Witherden DA; Boismenu R; Havran WL
    J Immunol; 2000 Aug; 165(4):1902-9. PubMed ID: 10925271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function.
    Serra A; Nuti S; Tavarini S; Sammicheli C; Rosa D; Saletti G; Soldaini E; Abrignani S; Wack A
    J Immunol; 2008 Jul; 181(1):174-85. PubMed ID: 18566382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
    Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
    J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
    Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
    McKean DJ; Huntoon CJ; Bell MP; Tai X; Sharrow S; Hedin KE; Conley A; Singer A
    J Immunol; 2001 Mar; 166(5):3468-75. PubMed ID: 11207305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.
    Sagi Y; Landrigan A; Levy R; Levy S
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1613-8. PubMed ID: 22307619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Behar SM; Porcelli SA; Beckman EM; Brenner MB
    J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
    J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
    Masuyama J; Kaga S; Kano S; Minota S
    J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytokine responses of murine CD8+ alphabeta intestinal intraepithelial lymphocytes by IL-4 and IL-12.
    Gelfanova V; Lai Y; Gelfanov V; Tzou S; Tu Y; Liao N
    J Biomed Sci; 1999; 6(4):269-76. PubMed ID: 10420084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.
    Waldrop SL; Davis KA; Maino VC; Picker LJ
    J Immunol; 1998 Nov; 161(10):5284-95. PubMed ID: 9820501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
    McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
    J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.